SOFIA (Bulgaria), March 2 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Monday that it more than tripled its consolidated net profit, excluding minority interest, to 91.4 million levs ($51.9 million/46.7 million euro) in 2019 from 28.3 million levs in 2018, backed by higher revenue.
about 4 hours agoabout 5 hours agoabout 5 hours agoabout 6 hours ago
about 4 hours agoabout 5 hours agoabout 5 hours agoabout 6 hours agoJun 10, 2026
BucharestJun 30, 2026Marrakech
